How should I structure my training programme when running Boldabol 200?

Structure your cycle into three blocks: accumulation (weeks 1–6), intensification (weeks 7–14), and realisation (week 15+). During the accumulation phase, increase weekly set volume by approximately 10% every two weeks. As boldenone reaches steady-state plasma levels around week 5–6, shift emphasis toward heavier compound lifts with moderate volume reduction. This periodisation model extracts the most lean-mass benefit from Boldabol 200's sustained anabolic environment.

What is the optimal weekly training volume when using boldenone undecylenate at 200mg/ml?

Most intermediate athletes tolerate 16–22 working sets per muscle group per week during a boldenone cycle, compared to 12–16 sets in a natural training block. Boldabol 200's erythropoietic support improves between-session oxygen delivery, expanding recoverable volume. Begin at your natural ceiling and add two sets per muscle group per week during the accumulation phase, monitoring session RPE and sleep quality as recovery indicators.

How do I adjust my cardio programming to match a Boldabol 200 cycle?

Keep aerobic conditioning at low-to-moderate intensity — Zone 2 heart-rate work for 20–30 minutes per session, three times per week. Boldenone undecylenate raises haematocrit through renal erythropoietin stimulation; high-volume high-intensity cardio stacked on top of this haematopoietic effect can push haematocrit into ranges that require medical review. Steady-state cardio supports cardiovascular conditioning without compounding erythropoietic load.

What is the minimum accurate dose I can draw from a 200mg/ml vial using an insulin syringe?

A 1ml insulin syringe graduated in 0.01ml increments allows a minimum accurate draw of 0.1ml, corresponding to 20mg at 200mg/ml. For the typical 100mg weekly microdose increment, you draw exactly 0.5ml — a clean, unambiguous graduation mark on any standard syringe. The 200mg/ml concentration delivers greater dose resolution per graduation mark than higher-concentration presentations, which is a practical advantage at conservative weekly doses.

How should I store Boldabol 200 after opening the vial, and does the 10ml multi-dose format require any special handling?

Store Boldabol 200 at room temperature between 15–25°C, away from direct light and moisture; refrigeration is not required but is acceptable. After the first puncture, use a fresh sterile needle for every draw to maintain septum integrity — the 10ml vial supports multiple injections across a cycle when handled with aseptic technique. Discard the vial if the solution becomes cloudy, discoloured, or shows any particulate matter. (2) angle_used

Recomp Optimizer

British Dragon

Boldabol 200 200mg/ml 10ml Vial by British Dragon

Name: Boldabol 200
Brand: British Dragon
SKU: INJ-BOLD-BRD-200-028
Price: 28.00 EUR
Availability: InStock

Boldabol 200 is an injectable boldenone undecylenate solution at 200mg/ml supplied in a 10ml multi-dose vial, engineered for athletes who structure their training programme around anabolic cycle phases to maximise lean-mass retention and work-capacity output. At 200mg/ml, the lower concentration supports precise weekly volume adjustments that align naturally with progressive training load periodisation. Batch integrity is confirmed through HPLC potency assay and LAL endotoxin screening applied prior to release; every vial leaving British Dragon's GMP-certified facility carries a traceable Certificate of Analysis.

€28.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Supports progressive training volume increases by accelerating inter-session muscular recovery
Erythropoietic activity raises oxygen delivery capacity, improving aerobic work threshold during resistance blocks
200mg/ml concentration enables 100mg dose increments in exact 0.5ml syringe draws — no fractional estimates
Long ester provides a stable anabolic environment across multi-week training periodisation blocks
Low aromatisation rate reduces estrogenic water retention, keeping bodyweight data meaningful during tracked training phases
Satellite cell upregulation supports connective tissue remodelling alongside hypertrophic muscle adaptation
10ml vial format supplies sufficient volume for a full periodised training block without mid-cycle reorder

Phase	dosage	Note
Accumulation (Weeks 1–6)	200–300mg/week (1.0–1.5ml)	Match dose ramp to 10% weekly volume increase in training; draw in 0.5ml increments
Intensification (Weeks 7–14)	300–400mg/week (1.5–2.0ml)	Load increases as training volume moderates; schedule haematocrit panel at week 6 before escalating
Realisation (Weeks 15+)	200–300mg/week (1.0–1.5ml)	Reduce dose as training shifts to peak-strength expression; plan final injection timing with PCT window

Key takeaways

Align weekly training volume increases with boldenone's plasma accumulation curve.
Schedule bloodwork at the accumulation-to-intensification block transition around week 6.
Draw precise 100mg increments as clean 0.5ml marks at 200mg/ml.
Cap resistance sessions at 75 minutes to protect the androgenic anabolic signal.
Limit cardio to Zone 2 intensity to avoid compounding erythropoietic load.

Boldabol 200: Boldenone Undecylenate Designed Around In-Cycle Training Structure

Boldabol 200 by British Dragon delivers boldenone undecylenate at 200mg/ml as an injectable anabolic agent specifically suited to athletes who treat their training programme as the primary variable their cycle must support — not the other way around. Boldenone undecylenate promotes progressive nitrogen retention in skeletal muscle, allowing trained athletes to sustain higher weekly training volumes without crossing into net-catabolic recovery debt. British Dragon manufactures Boldabol 200 under GMP conditions, with HPLC concentration verification and LAL endotoxin testing applied batch-by-batch.

How Boldabol 200 Interacts with Training Volume and Intensity

Training volume tolerance increases measurably during a boldenone undecylenate cycle because elevated erythropoietin-driven haematocrit supports aerobic recovery between sets and sessions. Compared to running identical training blocks without anabolic support, athletes on Boldabol 200 typically report improved inter-session recovery, allowing a shift from three to four working sessions per muscle group per week without accumulating excessive fatigue. Boldenone undecylenate enhances satellite cell activity, which accelerates connective tissue remodelling — a factor often underweighted when designing in-cycle programme volume. Recommended training frequency during a Boldabol 200 cycle is four to five resistance sessions per week, with aerobic conditioning kept at low-to-moderate intensity to avoid erythropoietic overload.

Periodisation Strategy During a Boldabol 200 Cycle

A structured in-cycle training block divides across three phases: an accumulation phase in weeks 1–6 where weekly set volume climbs by roughly 10% every two weeks, an intensification phase in weeks 7–14 where load increases as volume is modestly reduced, and a realisation phase in weeks 15 onward where absolute strength or conditioning output is tested. Boldabol 200's 200mg/ml concentration allows weekly dose adjustments of 100mg in 0.5ml increments, making it straightforward to synchronise dose increases with training block transitions. Athletes should schedule bloodwork — haematocrit, lipid panel, and serum markers — at the transition point between the accumulation and intensification phases, typically around week 6, to confirm physiological readiness before escalating training demand.

Practical In-Cycle Programme Points

Prioritise compound movements (squat, deadlift, press) during the intensification phase when boldenone's anabolic environment is most established.
Limit single-session duration to 75 minutes to avoid cortisol-mediated suppression of the androgenic signal.
Log session RPE weekly — a sustained drop in perceived exertion at fixed loads is a reliable early indicator that plasma boldenone levels have reached a productive steady state.

Usage

Establish pre-cycle baseline bloodwork — haematocrit, lipid panel, and serum testosterone — at least one week before the first injection.
Map your training periodisation block onto paper before injecting: define accumulation, intensification, and realisation phases with target weekly set volumes for each.
Draw Boldabol 200 using a fresh sterile needle each time; at 200mg/ml, measure 0.5ml per 100mg using a standard 3ml syringe for accuracy.
Administer via intramuscular injection into the glute or lateral quad; rotate injection sites across each weekly split to reduce local tissue stress.
Track session RPE, bodyweight, and sleep quality weekly — a sustained improvement in all three around weeks 5–6 signals that plasma boldenone has reached productive steady-state and training intensity can be escalated.
At the accumulation-to-intensification transition (approximately week 6), retest haematocrit and lipid markers before increasing both dose and training load.

Warnings

Contraindications: Individuals aged under 21, women of reproductive age, and those carrying a diagnosis of cardiovascular disease, polycythaemia, or any androgen-sensitive malignancy must not use this preparation. A baseline haematocrit reading at or above 50% is an absolute exclusion criterion prior to commencing any cycle.

Side Effects: Through stimulation of renal erythropoietin output, boldenone undecylenate raises red cell mass and haematocrit; when left unmonitored, the resultant increase in blood viscosity carries meaningful thromboembolic risk. Skin-related androgenic changes — notably acne, excess sebum secretion, and hastened scalp hair loss in those with a genetic predisposition — are recognised adverse outcomes. At every therapeutic dose, suppression of the body's own testosterone synthesis must be anticipated.

Monitoring: Venous bloods encompassing haematocrit, the HDL/LDL ratio, hepatic transaminases (ALT and AST), and serum testosterone are required at both the six-week and twelve-week marks of any cycle. A haematocrit value exceeding 52% mandates prompt dose reduction and referral for medical assessment. Given the erythropoietic activity inherent to this compound, weekly self-measurement of blood pressure is strongly advisable throughout.

PCT: The prolonged hydrolysis characteristic of the undecylenate ester means that a waiting period of roughly four to five weeks following the last injection is necessary before any SERM-based post-cycle therapy is started. Once the SERM block has concluded, laboratory measurement of LH, FSH, and total testosterone should be performed to verify that hypothalamic-pituitary-testicular axis function has been adequately restored.

Frequently asked questions

How should I structure my training programme when running Boldabol 200?: Structure your cycle into three blocks: accumulation (weeks 1–6), intensification (weeks 7–14), and realisation (week 15+). During the accumulation phase, increase weekly set volume by approximately 10% every two weeks. As boldenone reaches steady-state plasma levels around week 5–6, shift emphasis toward heavier compound lifts with moderate volume reduction. This periodisation model extracts the most lean-mass benefit from Boldabol 200's sustained anabolic environment.
What is the optimal weekly training volume when using boldenone undecylenate at 200mg/ml?: Most intermediate athletes tolerate 16–22 working sets per muscle group per week during a boldenone cycle, compared to 12–16 sets in a natural training block. Boldabol 200's erythropoietic support improves between-session oxygen delivery, expanding recoverable volume. Begin at your natural ceiling and add two sets per muscle group per week during the accumulation phase, monitoring session RPE and sleep quality as recovery indicators.
How do I adjust my cardio programming to match a Boldabol 200 cycle?: Keep aerobic conditioning at low-to-moderate intensity — Zone 2 heart-rate work for 20–30 minutes per session, three times per week. Boldenone undecylenate raises haematocrit through renal erythropoietin stimulation; high-volume high-intensity cardio stacked on top of this haematopoietic effect can push haematocrit into ranges that require medical review. Steady-state cardio supports cardiovascular conditioning without compounding erythropoietic load.
What is the minimum accurate dose I can draw from a 200mg/ml vial using an insulin syringe?: A 1ml insulin syringe graduated in 0.01ml increments allows a minimum accurate draw of 0.1ml, corresponding to 20mg at 200mg/ml. For the typical 100mg weekly microdose increment, you draw exactly 0.5ml — a clean, unambiguous graduation mark on any standard syringe. The 200mg/ml concentration delivers greater dose resolution per graduation mark than higher-concentration presentations, which is a practical advantage at conservative weekly doses.
How should I store Boldabol 200 after opening the vial, and does the 10ml multi-dose format require any special handling?: Store Boldabol 200 at room temperature between 15–25°C, away from direct light and moisture; refrigeration is not required but is acceptable. After the first puncture, use a fresh sterile needle for every draw to maintain septum integrity — the 10ml vial supports multiple injections across a cycle when handled with aseptic technique. Discard the vial if the solution becomes cloudy, discoloured, or shows any particulate matter. (2) angle_used

Manufacturer

British Dragon was established in Thailand in the early 2000s and became one of the first underground-to-pharmaceutical-grade anabolic manufacturers to gain widespread recognition in English-speaking bodybuilding markets. The brand built its initial reputation on accessible, clearly labelled injectable preparations at a time when concentration consistency in the underground market was erratic. Subsequent years saw British Dragon undergo significant restructuring; the contemporary iteration operates under documented GMP-aligned manufacturing standards with HPLC batch testing and LAL endotoxin screening as standard release criteria. Boldabol 200 represents the brand's 200mg/ml boldenone undecylenate offering — a deliberate lower-concentration format designed to serve athletes prioritising dosing precision over injection-volume economy.

Product details

Brand	British Dragon
Active ingredient	boldenone undecylenate
Also known as	Equipoise, EQ, Boldenone Undecylenate, Boldabol 200, British Dragon Equipoise
Strength	200 mg
Form	Vial
Pack size	1 piece
Item number	INJ-BOLD-BRD-200-028

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00

Stack it with

Pairs well with these products.

High Concentration